Azilsartan improves the effects of etanercept in patients with active rheumatoid arthritis: a pilot study

References

• SuzukiAYamamotoKFrom genetics to functional insights into rheumatoid arthritisClin Exp Rheumatol2015334 Suppl 92S40S43
   PubMed Web of Science ®Google Scholar
• PicernoVFerroFAdinolfiAValentiniETaniCAlunnoAOne year in review: the pathogenesis of rheumatoid arthritisClin Exp Rheumatol201533455155826203933
   PubMed Web of Science ®Google Scholar
• LampropoulosCEOrfanosPBourniaVKAdverse events and infections in patients with rheumatoid arthritis treated with conventional drugs or biologic agents: a real world studyClin Exp Rheumatol201533221622425664400
   PubMed Web of Science ®Google Scholar
• López-GonzálezRLeónLLozaERedondoMGarcia de YébenesMJCarmonaLAdherence to biologic therapies and associated factors in rheumatoid arthritis, spondyloarthritis and psoriatic arthritis: a systematic literature reviewClin Exp Rheumatol201533455956925602291
   PubMed Web of Science ®Google Scholar
• PhullARNasirBHaqIUKimSJOxidative stress, consequences and ROS mediated cellular signaling in rheumatoid arthritisChem Biol Interact201828112113629258867
   PubMed Web of Science ®Google Scholar
• HussainSAMortadaAHJasimNAGorialFISilibinin improves the effects of methotrexate in patients with active rheumatoid arthritis: pilot clinical studyOman Med J201631426326927403238
   PubMedGoogle Scholar
• NguyenGRenin, (pro)renin and receptor: an updateClin Sci (Lond)2011120516917821087212
   PubMed Web of Science ®Google Scholar
• Ruiz-OrtegaMLorenzoOSuzukiYRupérezMEgidoJProinflammatory actions of angiotensinsCurr Opin Nephrol Hypertens200110332132911342793
   PubMed Web of Science ®Google Scholar
• PengJGurantzDTranVCowlingRTGreenbergBHTumor necrosis factor-alpha-induced AT1 receptor upregulation enhances angiotensin II-mediated cardiac fibroblast responses that favor fibrosisCirc Res200291121119112612480812
   PubMed Web of Science ®Google Scholar
• WassmannSStumpfMStrehlowKInterleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptorCirc Res200494453454114699015
   PubMed Web of Science ®Google Scholar
• WangDHuSZhuJAngiotensin II type 2 receptor correlates with therapeutic effects of losartan in rats with adjuvant-induced arthritisJ Cell Mol Med201317121577158724112447
   PubMed Web of Science ®Google Scholar
• RefaatRSalamaMAbdel MeguidEEl SarhaAGowayedMEvaluation of the effect of losartan and methotrexate combined therapy in adjuvant-induced arthritis in ratsEur J Pharmacol20136981–342142823117086
   PubMed Web of Science ®Google Scholar
• BiliavskaIStammTAMartinez-AvilaJApplication of the 2010 ACR/EULAR classification criteria in patients with very early inflammatory arthritis: analysis of sensitivity, specificity and predictive values in the SAVE study cohortAnn Rheum Dis20137281335134122984174
   PubMed Web of Science ®Google Scholar
• van RielPLTaggartAJSanyJEfficacy and safety of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: the ADORE studyAnn Rheum Dis200665111478148316464988
   PubMed Web of Science ®Google Scholar
• PrevooMLvan ‘t HofMAKuperHHvan LeeuwenMAvan de PutteLBvan RielPLModified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis Rheum199538144487818570
   PubMed Web of Science ®Google Scholar
• SmolenJSBreedveldFCSchiffMHA simplified disease activity index for rheumatoid arthritis for use in clinical practiceRheumatology200342224425712595618
   PubMed Web of Science ®Google Scholar
• GhoshAGhoshBPainSComparison between DAS28, CDAI and HAQ-DI as tools to monitor early rheumatoid arthritis patients in eastern IndiaIndian Journal of Rheumatology201163116122
   Google Scholar
• MenkMGrawJAvon HaefenCStimulation of the Angiotensin II AT2 Receptor is Anti-inflammatory in Human Lipopolysaccharide-Activated Monocytic CellsInflammation20153841690169925758542
   PubMed Web of Science ®Google Scholar
• WangXKhaidakovMDingZCross-talk between inflammation and angiotensin II: studies based on direct transfection of cardiomyocytes with AT1R and AT2R cDNAExp Biol Med20122371213941401
   PubMed Web of Science ®Google Scholar
• PaulMPoyan MehrAKreutzRPhysiology of local renin-angiotensin systemsPhysiol Rev200686374780316816138
   PubMed Web of Science ®Google Scholar
• WeirMREffects of renin-angiotensin system inhibition on end-organ protection: can we do better?Clin Ther20072991803182418035185
   PubMed Web of Science ®Google Scholar
• NatarajCOliverioMIMannonRBAngiotensin II regulates cellular immune responses through a calcineurin-dependent pathwayJ Clin Invest1999104121693170110606623
   PubMed Web of Science ®Google Scholar
• KojimaCKawakamiATakeiTNittaKYoshidaMAngiotensin-converting enzyme inhibitor attenuates monocyte adhesion to vascular endothelium through modulation of intracellular zincJ Pharmacol Exp Ther2007323385586017878405
   PubMed Web of Science ®Google Scholar
• Al-HijjajWKNumanITAl-Sa’adRZHussainSAAnti-inflammatory activity of telmisartan in rat models of experimentally-induced chronic inflammation: Comparative study with dexamethasoneSaudi Pharm J2011191293423960739
   PubMed Web of Science ®Google Scholar
• TsuruokaSKaiHUsuiJEffects of irbesartan on inflammatory cytokine concentrations in patients with chronic glomerulonephritisIntern Med201352330330823370736
   PubMed Web of Science ®Google Scholar
• PangTBenickyJWangJOrecnaMSanchez-LemusESaavedraJMTelmisartan ameliorates lipopolysaccharide-induced innate immune response through peroxisome proliferator-activated receptor-γ activation in human monocytesJ Hypertens2012301879622124178
   PubMed Web of Science ®Google Scholar
• LiuHMaoPWangJWangTXieCHAzilsartan, an angiotensin II type 1 receptor blocker, attenuates tert-butyl hydroperoxide-induced endothelial cell injury through inhibition of mitochondrial dysfunction and anti-inflammatory activityNeurochem Int201694485626879328
   PubMed Web of Science ®Google Scholar
• HussainSAUtbaRMAssumaidaeeAMEffects of Azilsartan, Aliskiren or their Combination on High Fat Diet-induced Non-alcoholic Liver Disease Model in RatsMed Arch201771425125528974844
   PubMedGoogle Scholar
• SilveiraKDCoelhoFMVieiraATMechanisms of the anti-inflammatory actions of the angiotensin type 1 receptor antagonist losartan in experimental models of arthritisPeptides201346536323727291
   PubMed Web of Science ®Google Scholar
• BlümlSRedlichKSmolenJSMechanisms of tissue damage in arthritisSemin Immunopathol201436553154025212687
   PubMed Web of Science ®Google Scholar
• de AraújoAAVarelaHde MedeirosCAAzilsartan reduced TNF-α and IL-1β levels, increased IL-10 levels and upregulated VEGF, FGF, KGF, and TGF-α in an oral mucositis modelPLoS One2015102e011679925689279
   PubMed Web of Science ®Google Scholar
• Ruiz-OrtegaMLorenzoORupérezMKönigSWittigBEgidoJAngiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanismsCirc Res200086121266127210864918
   PubMed Web of Science ®Google Scholar
• SuzukiYRuiz-OrtegaMLorenzoORuperezMEstebanVEgidoJInflammation and angiotensin IIInt J Biochem Cell Biol200335688190012676174
   PubMed Web of Science ®Google Scholar
• WalshDASuzukiTKnockGABlakeDRPolakJMWhartonJAT1 receptor characteristics of angiotensin analogue binding in human synoviumBr J Pharmacol199411224354428075862
   PubMed Web of Science ®Google Scholar
• WalshDACatravasJWhartonJAngiotensin converting enzyme in human synovium: increased stromal [(125)I]351A binding in rheumatoid arthritisAnn Rheum Dis200059212513110666168
   PubMed Web of Science ®Google Scholar
• VealeDYanniGBresnihanBFitzgeraldOProduction of angiotensin converting enzyme by rheumatoid synovial membraneAnn Rheum Dis19925144764801316742
   PubMed Web of Science ®Google Scholar
• MahmoodNMAHussainSAKhanHAEKAzilsartan as “Add-On” Treatment with Methotrexate Improves the Disease Activity of Rheumatoid ArthritisBiomed Res Int20182018716429129888275
   PubMed Web of Science ®Google Scholar
• MatsushitaKYangHCMysoreMMEffects of combination PPARγ agonist and angiotensin receptor blocker on glomerulosclerosisLab Invest201696660260926999660
   PubMed Web of Science ®Google Scholar
• AndersonJCaplanLYazdanyJRheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practiceArthritis Care Res2012645640647
   PubMed Web of Science ®Google Scholar